CytomX Therapeutics Inc.

(CTMX)

By |

Profile

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company. is engaged in developing Probody therapeutics that address clinically-validated cancer targets in immuno-oncology, such as PD-L1, as well as targets, such as CD-166.

Contact Information

Website: www.cytomx.com
Main Phone: +1 650 515-3185
Address: 343 Oyster Point Boulevard
Address 2: Suite 100
State: CA
City / Town: South San Francisco
Country: USA
Postal Code: 94080

Issuer Information

Exchange: NGS
Employees: 65
NAICS: Pharmaceutical P
$ 11.00 $ 0.79 (7.74%)
Last Price 11.00 Change $ 0.79 Change % 7.74 Tick N/A
Bid 9.14 Bid Size 100.00 Ask N/A Ask Size 0.00
Open 10.30 High 11.28 Low 10.03 Prev Close 10.21
Last Trade Volume 144,200 52 Wk Hi 23.93 52 Wk Low 9.10
Market Cap 400.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 36,402,346.00 EPS (TTM) -5.27 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 16 34
Number of Buys 4 19
Number of Sells 12 15
Net Activity -226510 14636551
Last 10 Buys Shares
Flynn E James 1,000
Flynn E James 1,000
Cynthia Ladd 1,000
W. Michael Kavanaugh 1,000
Frederick W. Gluck 1,000
Frederick W. Gluck 1,000
Last 10 Sell Shares
Timothy M. Shannon 1,000
Timothy M. Shannon 1,000
Timothy M. Shannon 1,000
Timothy M. Shannon 1,000
Timothy M. Shannon 1,000
Timothy M. Shannon 1,000
Timothy M. Shannon 1,000
Timothy M. Shannon 1,000
Timothy M. Shannon 1,000
Timothy M. Shannon 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 22 22 22 22
Low Target Price Estimate 17 17 17 17
Mean Target Price Estimate 20 20 20 20
Standard Deviation 2.65 2.65 2.65 2.65
Date of Most Recent Estimate 08/10/16 08/03/16 07/18/16 08/10/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 3 4 4
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1